Kantum Pharma
Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Kantum Pharma Information
Geographic Data
Address:
City: Concord
State: New Hampshire
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$4M
Raised Total:$4M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kantum is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI. This targeted therapy will be supported by development of a novel diagnostic test for AKI. Kantum Bio is developing two programs in parallel: (1) Selective receptor antagonist-based therapeutics for AKI and (2) a UDP-G diagnostic test. Kantum’s lead therapeutic development candidate, KB-1801, will be developed for the prophylaxis and treatment of AKI secondary to cardiovascular intervention. Furthermore, KB-1801 has potential in cardiovascular accidents and other conditions associated with AKI in the ICU (e.g. sepsis, polytrauma, nephrotoxicity). The UDP-G diagnostic test will enable early diagnosis of patients at risk for AKI and may be leveraged to select patients and guide their treatment in clinical studies and, ultimately, in clinical practice.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Venture Round | 1 | - |
Broadview Ventures Broadview Ventures |
1/2019 | Convertible Note | 1 | - |
Sidecar Angels Sidecar Angels |
7/2021 | Series A | $0 |
10X Venture Partners Broadview Ventures 10X Venture Partners Broadview Ventures |
7/2021 | Series A | 2 | $3.5M |
10X Venture Partners Broadview Ventures 10X Venture Partners Broadview Ventures |
1/2020 | Venture Round | 1 | - |
Broadview Ventures Broadview Ventures |
1/2019 | Convertible Note | 1 | - |
Sidecar Angels Sidecar Angels |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
